TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: Impact on disease susceptibility and hepatocellular carcinoma traits

Tissue Antigens

Volumn 80, Issue 2, 2012, Pages 151-157

  Li, Z ^a   Liu, Z ^a   Zhang, G ^a   Han, Q ^a   Li, N ^a   Zhu, Q ^a   Lv, Y ^a   Chen, J ^a   Xing, F ^a   Wang, Y ^a   Li, F ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Chronic hepatitis B virus infection; Hepatocellular carcinoma; Polymorphism; Susceptibility; TIM3

Indexed keywords

ARTICLE; CANCER GRADING; CHRONIC HEPATITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; GENE; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN CONTAINING MOLECULE 3 GENE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; T-LYMPHOCYTES;

HEPATITIS B VIRUS;

EID: 84864374705     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01898.x     Document Type: Article

References (30)

1. Lai CL, Yuen MF. Chronic hepatitis B - new goals, new treatment. N Engl J Med 2008: 359: 2488-91.
2. Maini MK, Boni C, Lee CK et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000: 191: 1269-80.
3. Boni C, Fisicaro P, Valdatta C et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007: 81: 4215-25.
4. Fisicaro P, Valdatta C, Massari M et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010: 138: 682-93.
5. Blackburn SD, Shin H, Haining WN et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009: 10: 29-37.
6. Schurich A, Khanna P, Lopes AR et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011: 53: 1494-503.
7. Monney L, Sabatos CA, Gaglia JL et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002: 415: 536-41.
8. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT. The costimulatory role of TIM molecules. Immunol Rev 2009: 229: 259-70.
9. Sabatos CA, Chakravarti S, Cha E et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003: 4: 1102-10.
10. Zhu C, Anderson AC, Schubart A et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005: 6: 1245-52.
11. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010: 235: 172-89.
12. Wu W, Shi Y, Li J, Chen F, Chen Z, Zheng M. Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection. Virol J 2011: 8: 113.
13. Ju Y, Hou N, Meng J et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 2010: 52: 322-9.
14. Fourcade J, Sun Z, Benallaoua M et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med 2010: 207: 2175-86.
15. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010: 207: 2187-94.
16. Duan S, Zhang G, Han Q et al. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients. Mol Biol Rep 2011: 38: 5125-32.
17. Zhang G, Liu Z, Duan S et al. Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection. Hum Immunol 2010: 71: 1209-13.
18. Hu L, Liu J, Chen X et al. CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol 2010: 71: 888-91.
19. Dehaghani AS, Kashef MA, Ghaemenia M et al. PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases. J Reprod Med 2009: 54: 25-31.
20. Cao B, Zhu L, Zhu S et al. Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer. Cancer Immunol Immunother 2010: 59: 1851-7.
21. Chae SC, Song JH, Pounsambath P et al. Molecular variations in Th1-specific cell surface gene Tim-3. Exp Mol Med 2004: 36: 274-8.
22. Zhang CC, Wu JM, Cui TP, Wang P, Pan SX. Study on relationship between polymorphism sites of TIM-3 and allergic asthma in a population of adult Hans from Hubei province of China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chin J Med Genet) 2006: 23: 74-7.
23. Brück P, Ramos-Lopez E, Bartsch W, Böhme A, Badenhoop K. TIM-3 polymorphisms in type 1 diabetes families. J Hum Genet 2008: 53: 559-64.
24. Li J, Liu Q, Wang P et al. Two single nucleotide polymor- phisms in TIM-3 gene promoter region are associated with asthma susceptibility in a Chinese Han population from Shandong Province. J Shandong Univ (Health Sci) 2006: 44: 1159-63.
25. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005: 15: 97-8.
26. Li Z, Zhang Z, He Z et al. A partition-ligation-combination- subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res 2009: 19: 519-23.
27. Huang X, Bai X, Cao Y et al. Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion. J Exp Med 2010: 207: 505-20.
28. Wu FH, Yuan Y, Li D et al. Endothelial cell-expressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-kappaB pathway. Oncol Rep 2010: 24: 693-9.
29. Zhang J, Daley D, Akhabir L et al. Lack of association of TIM3 polymorphisms and allergic phenotypes. BMC Med Genet 2009: 10: 62.
30. DeKruyff RH, Bu X, Ballesteros A et al. T cell/transmem- brane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol 2010: 184: 1918-30.